(Q39759022)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

review article

1 reference

title

Adverse effects of hypolipidaemic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

Knodel LC

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

Talbert RL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

10-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

Simulation of the Thyroid Hormone-Binding Protein Interactions in Human Plasma1

28 September 2019

cites work

1 reference

12 December 2020

Intestinal obstruction associated with cholestyramine therapy

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Antibiotics and neuromuscular function.

1 reference

12 December 2020

Jaundice occurring during nicotinic acid therapy for hypercholesteremia

1 reference

12 December 2020

Cholestyramine induced hyperchloremic metabolic acidosis

1 reference

12 December 2020

Drugs, alcohol and malabsorption

1 reference

12 December 2020

Clofibrate-induced ventricular arrhythmia

1 reference

12 December 2020

Premature contractions and clofibrate.

1 reference

12 December 2020

Letter: Reaction to clofibrate

1 reference

12 December 2020

Colestipol: a review of its pharmacological properties and therapeutic efficacy in patients with hypercholesterolaemia

1 reference

12 December 2020

Gemfibrozil in the treatment of dyslipidaemias in middle-aged male survivors of myocardial infarction

1 reference

12 December 2020

Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia

1 reference

12 December 2020

Clofibrate-Induced Antinuclear Factor and Lupus-like Syndrome

1 reference

12 December 2020

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

12 December 2020

Effect of cholestyramine on telepaque oral cholecystography.

1 reference

12 December 2020

Clofibrate-induced muscle damage in patients with chronic renal failure

1 reference

12 December 2020

Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction

1 reference

12 December 2020

Effect of gemfibrozil on serum lipids in man

1 reference

12 December 2020

Potentiation of Hypoglycemic Effect of Sulfonylureas by Clofibrate

1 reference

12 December 2020

Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia

1 reference

12 December 2020

Gemfibrozil in the treatment of dyslipidaemia. A 5-year follow-up study

1 reference

12 December 2020

Intestinal Obstruction Associated with Cholestyramine Therapy

1 reference

12 December 2020

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

12 December 2020

Techniques of postmarketing surveillance. An overview.

1 reference

12 December 2020

Cardiac tolerance for cholesteropenic doses of dextrothyroxine

1 reference

12 December 2020

Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and Clofibrate

1 reference

12 December 2020

Pharmacokinetics of drugs in patients with the nephrotic syndrome

1 reference

12 December 2020

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

1 reference

12 December 2020

Prevalence of gallstones in hyperlipidemia and incidence during treatment with clofibrate and/or cholestyramine

1 reference

12 December 2020

The clinical use of dextrothyroxine in hypercholesterolemic states. An eight-year appraisal

1 reference

12 December 2020

The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide

1 reference

12 December 2020

Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia

1 reference

12 December 2020

Safety of Therapy for Allergic Symptoms During Pregnancy

1 reference

12 December 2020

Prostacyclin production augmented in the short term by nicotinic acid

1 reference

12 December 2020

The effect of gemfibrozil on serum lipids in diabetic patients

1 reference

12 December 2020

Cholestyramine induced hyperchloremic metabolic acidosis

1 reference

12 December 2020

Cholestyramine and intestinal obstruction

1 reference

12 December 2020

Interaction by cholestyramine on the uptake of hydrocortisone in the gastrointestinal tract

1 reference

12 December 2020

Effect of cholestyramine on mineral excretion in man

1 reference

12 December 2020

Dextrothyroxine with propranolol in treatment of hypercholesterolaemia

1 reference

12 December 2020

The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.

1 reference

12 December 2020

Inhibition of iron absorption by cholestyramine. Demonstration of diminished iron stores following prolonged administration

1 reference

12 December 2020

Recurrent Cholestasis of Pregnancy: Treatment with Cholestyramine of one Case with an Unusually Early Onset

1 reference

12 December 2020

Treatment of Hypercholesterolemia with Neomycin — A Time for Reappraisal

1 reference

12 December 2020

Safety and effectiveness of probucol as a cholesterol lowering agent

1 reference

12 December 2020

Cholestipol hydrochloride, a new hypolipidemic drug: a two-year study-summary

1 reference

12 December 2020

Reduction in elevated blood cholesterol levels by large doses of nicotinic acid; preliminary report

1 reference

12 December 2020

Inhibition of clofibrate-induced antidiuresis by glybenclamide in patients with pituitary diabetes insipidus

1 reference

12 December 2020

Treatment of hypercholesterolemia after myocardial infarction with D-thyroxine (author's transl)

1 reference

12 December 2020

Osteomalacia Associated with Cholestyramine Therapy for Postileectomy Diarrhea

1 reference

12 December 2020

Acute Muscular Syndrome Associated with Administration of Clofibrate

1 reference

12 December 2020

Nicotinic acid in the treatment of hypercholesterolemia. A long term study

1 reference

12 December 2020

Effect of gemfibrozil on serum lipid levels

1 reference

12 December 2020

Rules of evidence and clinical recommendations on the use of antithrombotic agents

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

Obstetric Hepatosis: Treatment with Cholestyramine and Interim Response to Steroids

1 reference

12 December 2020

[Treatment of primary hyperlipoproteinemia type IIa and IIb with dextrothyroxine (author's transl)]

1 reference

12 December 2020

Effect of probucol in hyperlipidemic patients during two years of administration

1 reference

12 December 2020

A comparison of cholestyramine and probucol in the treatment of familial hypercholesterolaemia

1 reference

12 December 2020

Effect of probucol on plasma lipids and lipoproteins in type IIb hyperlipoproteinemia

1 reference

12 December 2020

Risk of haemorrhage associated with long term anticoagulant therapy

1 reference

12 December 2020

Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.

1 reference

12 December 2020

Effect of atromid and ethyl chlorophenoxyisobutyrate on anticoagulant requirements

1 reference

12 December 2020

Risks and benefits of nutritional supplements during pregnancy

1 reference

12 December 2020

Sensitization to epinephrine-induced ventricular fibrillation produced by probucol in dogs

1 reference

12 December 2020

Hypoprothrombinemia and Hemorrhage Associated with Cholestyramine Therapy

1 reference

12 December 2020

Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia

1 reference

12 December 2020

Effects of gemfibrozil on serum lipids

1 reference

12 December 2020

The anticoagulant response to bishydroxycoumarin. II. The effect of D-thyroxine, clofibrate, and norethandrolone

1 reference

12 December 2020

Probucol with colestipol in the treatment of hypercholesterolemia

1 reference

12 December 2020

Long-Term Oral Administration of Probucol [4, 4‘-(Isopropylidenedithio) bis (2, 6-di-t-Butylphenol)] (DH-581) in the Management of Hypercholesterolemia*

1 reference

12 December 2020

Treatment of primary lipoproteinemia type IIa and IIb with highly purified dextro-thyroxine (D-T4). Controlled study in ambulant conditions

1 reference

12 December 2020

Effect of Sodium Dextrothyroxine in Patients Receiving Anticoagulants

1 reference

12 December 2020

Hepatic fibrosis following long acting nicotinic acid therapy: a case report

1 reference

12 December 2020

Use of Cholestyramine Resin in Digitoxin Toxicity

1 reference

12 December 2020

Eosinophilia associated with cholestyramine

1 reference

12 December 2020

Colestipol therapy of hyperlipidemia in man.

1 reference

12 December 2020

Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.

1 reference

12 December 2020

Cholestyramine therapy and intestinal obstruction in infants

1 reference

12 December 2020

Warfarin dosage influenced by clofibrate plus age

1 reference

12 December 2020

Hyperchloremic metabolic acidosis with cholestyramine therapy for biliary cholestasis

1 reference

12 December 2020

Streptomycin ototoxicity in the unborn child.

1 reference

12 December 2020

Complications during clofibrate treatment of nephrotic-syndrome hyperlipoproteinaemia

1 reference

12 December 2020

Safety and Efficacy of Probucol During One Year of Administration

1 reference

12 December 2020

Nicotinic Acid Maculopathy

1 reference

12 December 2020

A 5 year double blind controlled clinical trial of D--thyroxine on euthyroid coronary subjects. Final report

1 reference

12 December 2020

Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia

1 reference

12 December 2020

Dextrothyroxine for lowering serum cholesterol. Analysis of data on 6066 patients

1 reference

12 December 2020

Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.

1 reference

12 December 2020

Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia

1 reference

12 December 2020

Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents

1 reference

12 December 2020

Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia

1 reference

12 December 2020

The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate

1 reference

12 December 2020

Letter: Cholestyramine and metabolic acidosis

1 reference

12 December 2020

Nicotinic acid and its derivatives: a short survey

1 reference

12 December 2020

Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortality

1 reference

12 December 2020

Toxic effects of water-soluble vitamins.

1 reference

12 December 2020

Long-term reduction of serum cholesterol levels of patients with atherosclerosis by small doses of neomycin

1 reference

12 December 2020

Clofibrate-lnduced acute muscular syndrome

1 reference

12 December 2020

The interaction between cholestyramine and drugs

1 reference

12 December 2020

Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure

1 reference

12 December 2020

Effect of gemfibrozil on biliary lipid metabolism in normolipemic subjects

1 reference

12 December 2020

The long-term effects of probucol on serum lipid levels

1 reference

12 December 2020

Effects of Neomycin Alone and in Combination with Cholestyramine on Serum Cholesterol and Fecal Steroids in Hypercholesterolemic Subjects

1 reference

12 December 2020

Long-term use of gemfibrozil (Lopid) in the treatment of dyslipidemia

1 reference

12 December 2020

Oral 25-hydroxyvitain D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy

1 reference

12 December 2020

Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia

1 reference

12 December 2020

Long-term treatment of hypercholesterolemia with colestipol hydrochloride

1 reference

12 December 2020

Intrauterine ototoxicity. A case report and review of literature

1 reference

12 December 2020

Elevated triiodothyronine and dextrothyroxine levels: a potential cause of iatrogenic hyperthyroidism

1 reference

12 December 2020

Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis

1 reference

12 December 2020

Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia

1 reference

12 December 2020

Toxic amblyopia associated with administration of nicotinic acid

1 reference

12 December 2020

Nine years of treatment with probucol

1 reference

12 December 2020

Letter: Effect of clonidine on nicotinic-acid flushing

1 reference

12 December 2020

Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis

1 reference

12 December 2020

A Comparative Study of the Effects of Cholestyramine and Neomycin in the Treatment of Type II Hyperlipoproteinaemia

1 reference

12 December 2020

Use of cholestyramine in treatment of children with familial hypercholesterolaemia

1 reference

12 December 2020

Colestipol in familial type II hyperlipoproteinemia: A three-year trial

1 reference

12 December 2020

Thyroid dysfunction in the neonatal period

1 reference

12 December 2020

Studies on the interaction of warfarin and clofibrate in man.

1 reference

12 December 2020

Clofibrate, Serum Enzymes, and Muscle Pain

1 reference

12 December 2020

Massive hemorrhage and death during treatment with clofibrate and warfarin

1 reference

12 December 2020

Electrocardiographic effects of probucol. A controlled prospective clinical trial

1 reference

12 December 2020

Effect of cholestyramine on digoxin absorption and excretion in man

1 reference

12 December 2020

Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen

1 reference

12 December 2020

Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial

1 reference

12 December 2020

The use of dextro-thyroxine (choloxin) in cardiovascular disease. Report of a clinical study

1 reference

12 December 2020

The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group

1 reference

12 December 2020

Postmarketing Surveillance of New Drugs: I. Review of Objectives and Methodology

1 reference

12 December 2020

Cholestyramine and spironolactone and their combination in digitoxin elimination

1 reference

12 December 2020

Drugs in pregnancy and lactation

1 reference

12 December 2020

1 reference

12 December 2020

Toxicity of (4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol)), probucol, in mice, rats, dogs and monkeys: demonstration of a species-specific phenomenon.

1 reference

12 December 2020

Drug interactions and side effects of hypolipidemic drugs

1 reference

12 December 2020

Effect of colestipol on gastrointestinal absorption of chlorothiazide in man

1 reference

12 December 2020

Drug-induced steatorrhea.

1 reference

12 December 2020

Inhibition of the intestinal absorption of inorganic and hemoglobin iron by cholestyramine

1 reference

12 December 2020

Nicotinic acid treatment of hypercholesteremia. Comparison of plain and sustained-action preparations and report of two cases of jaundice

1 reference

12 December 2020

Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens

1 reference

12 December 2020

Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil.

1 reference

12 December 2020

Inhibition of digoxin absorption by neomycin

1 reference

12 December 2020

Urinary excretion of reduced metabolites of digoxin

1 reference

12 December 2020

The effect of colestipol on digitoxin plasma levels

1 reference

12 December 2020

A long-term trial of gemfibrozil in the treatment of hyperlipidaemias

1 reference

12 December 2020

Drug-nutrient interaction

1 reference

12 December 2020

Pharmacology of hypolipidemic drugs. Introduction

1 reference

12 December 2020

Studies of nicotinic acid use in hypercholesteremia. Changes in hepatic function, carbohydrate tolerance, and uric acid metabolism

1 reference

12 December 2020

Interactions between digitoxin and other drugs in man

1 reference

12 December 2020

Clofibrate and enzymatic induction in man

1 reference

12 December 2020

Clinical Pharmacokinetics of Hypolipidaemic Drugs

1 reference

12 December 2020

Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia

1 reference

12 December 2020

Iatrogenic hyperthyroidism secondary to dextrothyroxine administration

1 reference

12 December 2020

Control of clofibrate toxicity in uremic hypertriglyceridemia

1 reference

12 December 2020

Digitalis intoxication. Treatment with a new steroid-binding resin

1 reference

12 December 2020

The Influence of Cholestyramine on Thyroxine Absorption

1 reference

12 December 2020

Severe liver dysfunction during nicotinic acid therapy

1 reference

12 December 2020

Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia

1 reference

12 December 2020

Probucol in hypercholesterolemia. A double blind study

1 reference

12 December 2020

Neomycin and plasma lipoproteins in type II hyperlipoproteinemia

1 reference

12 December 2020

Letter: Hyperchloremia, metabolic acidosis, and cholestyramine

1 reference

12 December 2020

Treatment of children with familial hypercholesterolaemia

1 reference

12 December 2020

Probable interaction of loperamide and cholestyramine

1 reference

12 December 2020

Effect of cholestyramine on absorption of3H digoxin in rats

1 reference

12 December 2020

Low-dose colestipol plus probucol for hypercholesterolemia

1 reference

12 December 2020

Hypernatremia associated with cholestyramine therapy

1 reference

12 December 2020

Probucol in the long-term treatment of hypercholesterolaemia

1 reference

12 December 2020

Combined therapy with cholestyramine and warfarin

1 reference

12 December 2020

Plasma Prekallikrein, Kallikrein Inhibitors, Kininogen and Lipids during Gemfibrozil Treatment in Type II Dyslipidaemia

1 reference

12 December 2020

Prolongation of the QT interval induced by probucol: demonstration of a method for determining QT interval change induced by a drug.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03259858

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3547004%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference